Related Experiment Video
Updated: Jul 18, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.
Stefano Pallanti1, Silvia Bernardi, Leonardo Quercioli
1Department of Psychiatry, Institute for Neuroscience, Florence University of Medicine, Florence, Italy. s.pallanti@agora.it
CNS Spectrums
|December 6, 2006
Summary
Pathological gamblers exhibit altered serotonin (5-HT) metabolism, showing increased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP). This suggests a potential marker for addiction vulnerability.
Area of Science:
- Neuroscience
- Psychiatry
- Addiction Research
Background:
- Serotonin (5-HT) system alterations are implicated in impulsive and addictive behaviors.
- Meta-chlorophenylpiperazine (m-CPP), a 5-HT agonist, can induce euphoria and craving.
- Pathological gambling is a non-substance addiction with potential serotonergic underpinnings.
Purpose of the Study:
- To investigate 5-HT metabolism in pathological gamblers compared to controls.
- To assess behavioral and neuroendocrine responses to m-CPP in pathological gambling.
- To explore the relationship between clinical severity and neuroendocrine outcomes.
Main Methods:
- Double-blind, placebo-controlled crossover study.
- 26 pathological gamblers and 26 controls received oral m-CPP (0.5 mg/kg) or placebo.
- Measured prolactin, cortisol, mood, craving, and "high" sensation.
Main Results:
- Pathological gamblers showed significantly higher prolactin responses to m-CPP.
- Increased gambling severity correlated with greater neuroendocrine responsiveness.
- Pathological gamblers reported a significantly stronger "high" sensation after m-CPP.
Conclusions:
- Findings support evidence of 5-HT dysregulation in pathological gambling.
- 5-HT dysfunction and the experience of "high" may drive dyscontrolled gambling behavior.
- m-CPP-induced "high" could be a vulnerability marker for addiction.
Related Concept Videos
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...